Brief: Viracta Therapeutics Q2 net income USD -9.8 million
14/08/2024 12:09
Aug 14 (Reuters) - Viracta Therapeutics Q2 EPS USD -0.25. * Q2 net income USD -9.8 million
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update